Vivos Therapeutics Announces Issuance of U.S. Patent No. 12,697,190

What Happened

• Vivos Therapeutics, Inc. announced in a press release dated August 5, 2026 that U.S. Patent No. 12,697,190 has been issued. The company furnished that press release as Exhibit 99.1 to a Form 8-K filed on August 11, 2026 under Item 7.01 (Regulation FD Disclosure).

Key Details

• Patent number: U.S. Patent No. 12,697,190.
• Press release date: August 5, 2026; Form 8-K filed: August 11, 2026.
• Disclosure item: Item 7.01 (Regulation FD Disclosure); press release furnished as Exhibit 99.1.

Why It Matters

• The issuance of a U.S. patent can strengthen Vivos’s intellectual property position around its technology, which may support product protection and future commercialization efforts.
• The filing is a disclosure of the patent announcement only; the 8-K does not provide financial details, expected revenue impact, or other material terms tied to the patent. Investors should view this as an IP development update rather than a financial forecast.